These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20465620)

  • 1. Antihistamines are superior to topical steroids in managing human immunodeficiency virus (HIV)-associated papular pruritic eruption.
    Navarini AA; Stoeckle M; Navarini S; Mossdorf E; Jullu BS; Mchomvu R; Mbata M; Kibatala P; Tanner M; Hatz C; Schmid-Grendelmeier P
    Int J Dermatol; 2010 Jan; 49(1):83-6. PubMed ID: 20465620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome?
    Castelnuovo B; Byakwaga H; Menten J; Schaefer P; Kamya M; Colebunders R
    AIDS; 2008 Jan; 22(2):269-73. PubMed ID: 18097229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pruritic papular eruption and eosinophilic folliculitis associated with human immunodeficiency virus (HIV) infection: a histopathological and immunohistochemical comparative study.
    Afonso JP; Tomimori J; Michalany NS; Nonogaki S; Porro AM
    J Am Acad Dermatol; 2012 Aug; 67(2):269-75. PubMed ID: 22521200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pruritic papular eruption in HIV: a case successfully treated with NB-UVB.
    Bellavista S; D' Antuono A; Infusino SD; Trimarco R; Patrizi A
    Dermatol Ther; 2013; 26(2):173-5. PubMed ID: 23551375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology of pruritic papular eruption with HIV infection in Uganda.
    Resneck JS; Van Beek M; Furmanski L; Oyugi J; LeBoit PE; Katabira E; Kambugu F; Maurer T; Berger T; Pletcher MJ; Machtinger EL
    JAMA; 2004 Dec; 292(21):2614-21. PubMed ID: 15572719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological study of pruritic papular eruptions in HIV-infected patients in relationship with CD4, CD8 counts.
    Annam V; Yelikar BR; Inamadar AC; Palit A
    Indian J Pathol Microbiol; 2009; 52(3):321-4. PubMed ID: 19679951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy.
    Siddique MA; Hartman KE; Dragileva E; Dondero M; Gebretsadik T; Shintani A; Peiperl L; Valentine F; Kalams SA
    J Infect Dis; 2006 Sep; 194(5):661-5. PubMed ID: 16897665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological Features of Pruritic Papular Eruption of HIV Patients seen in Benin-City, Nigeria.
    Ekpe O; Onunu AN; Forae GD; Okwara B
    West Afr J Med; 2020; 37(1):53-57. PubMed ID: 32030712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and treatment of itching in HIV-infected patients.
    Gelfand JM; Rudikoff D
    Mt Sinai J Med; 2001; 68(4-5):298-308. PubMed ID: 11514917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pruritic papular eruption in HIV.
    Eisman S
    Dermatol Clin; 2006 Oct; 24(4):449-57, vi. PubMed ID: 17010775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of treating atopic dermatitis with oral antihistamine and topical steroids on selected parameters of cell and humoral immunity].
    Guzik TJ; Adamek-Guzik T; Bzowska M; Miedzobrodzki J; Czerniawska-Mysik G; Pryjma J
    Folia Med Cracov; 2002; 43(1-2):79-93. PubMed ID: 12815801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pruritic urticarial papules and plaques of pregnancy: current status.
    Ahmadi S; Powell FC
    Australas J Dermatol; 2005 May; 46(2):53-8; quiz 59. PubMed ID: 15842394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological study of itchy folliculitis in HIV-infected patients.
    Annam V; Yelikar BR; Inamadar AC; Palit A; Arathi P
    Indian J Dermatol Venereol Leprol; 2010; 76(3):259-62. PubMed ID: 20445296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.
    Castagna A; Galli L; Torti C; D'Arminio Monforte A; Mussini C; Antinori A; Cozzi-Lepri A; Ladisa N; De Luca A; Seminari E; Gianotti N; Lazzarin A
    Antivir Ther; 2010; 15(2):165-75. PubMed ID: 20386071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts.
    Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI
    Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.
    Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA
    Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with pruritic papular eruption of human immunodeficiency virus infection in the antiretroviral therapy era.
    Chua SL; Amerson EH; Leslie KS; McCalmont TH; Leboit PE; Martin JN; Bangsberg D; Maurer TA
    Br J Dermatol; 2014 Apr; 170(4):832-9. PubMed ID: 24641299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness.
    Bocket L; Cheret A; Deuffic-Burban S; Choisy P; Gerard Y; de la Tribonnière X; Viget N; Ajana F; Goffard A; Barin F; Mouton Y; Yazdanpanah Y
    Antivir Ther; 2005; 10(2):247-54. PubMed ID: 15865219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous opioids, mu-opiate receptors and chloroquine-induced pruritus: a double-blind comparison of naltrexone and promethazine in patients with malaria fever who have an established history of generalized chloroquine-induced itching.
    Ajayi AA; Kolawole BA; Udoh SJ
    Int J Dermatol; 2004 Dec; 43(12):972-7. PubMed ID: 15569037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.
    Lacabaratz-Porret C; Urrutia A; Doisne JM; Goujard C; Deveau C; Dalod M; Meyer L; Rouzioux C; Delfraissy JF; Venet A; Sinet M
    J Infect Dis; 2003 Mar; 187(5):748-57. PubMed ID: 12599048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.